BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 33284575)

  • 1. Steroid-Peptide Immunoconjugates for Attenuating T Cell Responses in an Experimental Autoimmune Encephalomyelitis Murine Model of Multiple Sclerosis.
    Sands RW; Tabansky I; Verbeke CS; Keskin D; Michel S; Stern J; Mooney DJ
    Bioconjug Chem; 2020 Dec; 31(12):2779-2788. PubMed ID: 33284575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination with autologous dendritic cells: from experimental autoimmune encephalomyelitis to multiple sclerosis.
    Link H; Huang YM; Masterman T; Xiao BG
    J Neuroimmunol; 2001 Mar; 114(1-2):1-7. PubMed ID: 11240009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of nuclear factor-kappa B enhances the capacity of immature dendritic cells to induce antigen-specific tolerance in experimental autoimmune encephalomyelitis.
    Iruretagoyena MI; Sepúlveda SE; Lezana JP; Hermoso M; Bronfman M; Gutiérrez MA; Jacobelli SH; Kalergis AM
    J Pharmacol Exp Ther; 2006 Jul; 318(1):59-67. PubMed ID: 16597709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerogenic vaccines for Multiple sclerosis.
    Mannie MD; Curtis AD
    Hum Vaccin Immunother; 2013 May; 9(5):1032-8. PubMed ID: 23357858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,25-dihydroxyvitamin D
    Xie Z; Chen J; Zheng C; Wu J; Cheng Y; Zhu S; Lin C; Cao Q; Zhu J; Jin T
    Immunology; 2017 Nov; 152(3):414-424. PubMed ID: 28617989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells in experimental allergic encephalomyelitis and multiple sclerosis.
    Link H; Huang YM; Xiao BG
    J Neuroimmunol; 1999 Dec; 100(1-2):102-10. PubMed ID: 10695720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental autoimmune encephalomyelitis (EAE) induced by antigen pulsed dendritic cells in the C57BL/6 mouse: influence of injection route.
    Aghdami N; Gharibdoost F; Moazzeni SM
    Exp Anim; 2008 Jan; 57(1):45-55. PubMed ID: 18256518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerogenic Dendritic Cells Generated with Tofacitinib Ameliorate Experimental Autoimmune Encephalomyelitis through Modulation of Th17/Treg Balance.
    Zhou Y; Leng X; Luo S; Su Z; Luo X; Guo H; Mo C; Zou Q; Liu Y; Wang Y
    J Immunol Res; 2016; 2016():5021537. PubMed ID: 28070525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders.
    Chorny A; Gonzalez-Rey E; Fernandez-Martin A; Pozo D; Ganea D; Delgado M
    Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13562-7. PubMed ID: 16150720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The change of PD1, PDL1 in experimental autoimmune encephalomyelitis treated by 1,25(OH)
    Cao Q; Zheng C; Xie Z; Liu L; Zhu J; Jin T
    J Neuroimmunol; 2020 Jan; 338():577079. PubMed ID: 31731230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4
    Moorman CD; Curtis AD; Bastian AG; Elliott SE; Mannie MD
    Front Immunol; 2018; 9():3119. PubMed ID: 30687323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-1 is essential for the induction of MOG35-55 -based intravenous tolerance in experimental autoimmune encephalomyelitis.
    Mari ER; Rasouli J; Ciric B; Moore JN; Conejo-Garcia JR; Rajasagi N; Zhang GX; Rabinovich GA; Rostami A
    Eur J Immunol; 2016 Jul; 46(7):1783-96. PubMed ID: 27151444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis.
    Calvo-Barreiro L; Eixarch H; Ponce-Alonso M; Castillo M; Lebrón-Galán R; Mestre L; Guaza C; Clemente D; Del Campo R; Montalban X; Espejo C
    Cells; 2020 Apr; 9(4):. PubMed ID: 32272791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective depletion of CD11c
    Wang L; Li Z; Ciric B; Safavi F; Zhang GX; Rostami A
    Eur J Immunol; 2016 Oct; 46(10):2454-2466. PubMed ID: 27338697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiantigen/multiepitope-directed immune-specific suppression of "complex autoimmune encephalomyelitis" by a novel protein product of a synthetic gene.
    Zhong MC; Kerlero de Rosbo N; Ben-Nun A
    J Clin Invest; 2002 Jul; 110(1):81-90. PubMed ID: 12093891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-specific T cells in autoimmune diseases with a focus on multiple sclerosis and experimental allergic encephalomyelitis.
    Xiao BG; Link H
    Cell Mol Life Sci; 1999 Oct; 56(1-2):5-21. PubMed ID: 11213261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of MS-like disease by a multi epitope protein is mediated by induction of CD11c
    Kaushansky N; Kaminitz A; Allouche-Arnon H; Ben-Nun A
    J Neuroimmunol; 2019 Aug; 333():476953. PubMed ID: 31108399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol to assess the tolerogenic properties of adoptively transferred dendritic cells during murine experimental autoimmune encephalomyelitis.
    Vogel A; Kerndl M; Schabbauer G; Sharif O
    STAR Protoc; 2022 Sep; 3(3):101653. PubMed ID: 36065293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting DEC-205
    Tabansky I; Keskin DB; Watts D; Petzold C; Funaro M; Sands W; Wright P; Yunis EJ; Najjar S; Diamond B; Cao Y; Mooney D; Kretschmer K; Stern JNH
    Mol Med; 2018 May; 24(1):17. PubMed ID: 30134798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of regulatory T cells in multiple sclerosis.
    Zozulya AL; Wiendl H
    Nat Clin Pract Neurol; 2008 Jul; 4(7):384-98. PubMed ID: 18578001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.